Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Taproot Health
Scripps Health
Celgene
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Shenzhen BinDeBio Ltd.
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Wake Forest University Health Sciences
University of Arizona
GlaxoSmithKline
Novartis
Mirna Therapeutics, Inc.
M.D. Anderson Cancer Center
Stanford University
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
Northside Hospital, Inc.
Case Comprehensive Cancer Center